Clinical Trials Browser

Lymphoma, B-Cell × ALT-803 × 90 days × Clear all

NCT07049432 2026-04-01

CARMEN-803

Phase 1 Withdrawn

Lymphoma, B-Cell

NCT07477366 2026-03-17

Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma

Phase 2 Not yet recruiting

Lymphoma, B-Cell